Daily news email for February 21, 2012 | Click here for updated news
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report
Proposed FDA Budget Leans on Industry
Gilead Drops on Poor Clinical Trials Results of Pharmasset Drug
Rusnano Invests in Novel Diagnostics
Despite Cuts, Big Pharma Says It's Still Overstaffed
Amyris Scales Back
|
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
